tiprankstipranks
Trending News
More News >

New Portfolio Jan 2023 - New Portfolio

Assen

New Portfolio Jan 2023
Individual Investor
Ranked #520,684 out of 822,572 TipRanks' Investors
Success Rate
43%
48 out of 113
profitable transactions
Average Return
3.41%
Average return
per transaction
Share this portfolio:

Portfolio Gain

1-Month Return▲ 5.02%
6-Month Return▲ 16.95%
12-Month Return▲ 2.04%
YTD Return▲ 5.83%
Total Return▲ 8.58%

Best Trade

Opened at
Closed at-
Gain▲ 313.21%

Bio

LT focused portfolio with primary investment in EU based companies

Performance

12.88%0-12.88%
▼ 6.38%
▼ 5.57%
▼ 9.94%
Mar 2025
▲ 0.80%
▼ 0.87%
▼ 3.30%
Apr 2025
▲ 11.63%
▲ 6.28%
▲ 2.80%
May 2025
▲ 9.25%
▲ 5.14%
▼ 1.52%
Jun 2025
▲ 7.60%
▲ 2.30%
▲ 2.80%
Jul 2025
▲ 2.76%
▲ 2.05%
▲ 3.98%
Aug 2025
▲ 12.88%
▲ 3.56%
▲ 0.28%
Sep 2025
▲ 6.67%
▲ 0.75%
▲ 3.41%
Oct 2025
TipRanks AverageS&P 500Investor Portfolio
▼ 6.38%▼ 5.57%▼ 9.94%
▲ 0.80%▼ 0.87%▼ 3.30%
▲ 11.63%▲ 6.28%▲ 2.80%
▲ 9.25%▲ 5.14%▼ 1.52%
▲ 7.60%▲ 2.30%▲ 2.80%
▲ 2.76%▲ 2.05%▲ 3.98%
▲ 12.88%▲ 3.56%▲ 0.28%
▲ 6.67%▲ 0.75%▲ 3.41%

Recent Activity

Company Name
% of Portfolio
Return
No. of Transactions
Last Transaction
Date
Sanofi
0%
▼ 2.19%
4
Sell
Aug 17, 2025
Kering SA
0%
▼ 14.44%
6
Sell
Aug 17, 2025
Novo Nordisk
21.97%
▼ 28.03%
8
Buy
Aug 17, 2025
The Estée Lauder Companies
0%
▼ 14.78%
7
Sell
Aug 17, 2025
Tesla
9.73%
▲ 76.68%
3
Buy
Aug 17, 2025
Nvidia
8.61%
▲ 129.94%
5
Buy
Aug 17, 2025
EssilorLuxottica SA
5.78%
▲ 24.23%
3
Buy
Aug 17, 2025
LVMH Moet Hennessy Louis Vuitton
12.11%
▼ 4.47%
4
Buy
Aug 17, 2025
Barry Callebaut AG
0%
▼ 24.13%
2
Sell
Aug 17, 2025
Eli Lilly & Co
6.38%
▲ 22.22%
1
Open
Aug 17, 2025
Remy Cointreau
1.21%
▼ 50.64%
7
Buy
May 14, 2025
Brown Forman A
0.61%
▼ 39.27%
4
Buy
May 14, 2025
L'Oreal
3.26%
▼ 6.74%
2
Buy
May 14, 2025
TotalEnergies SE
4.43%
▼ 8.66%
2
Buy
May 14, 2025
Air Liquide
▲ 13.40%
4
Close
Sep 27, 2024
Ferrari
0%
▼ 8.10%
2
Sell
Sep 27, 2024
AXA SA
0%
▲ 24.46%
2
Sell
Sep 27, 2024
Alibaba
0%
▲ 103.72%
2
Sell
Sep 27, 2024
Compagnie Financiere Richemont SA
▼ 5.60%
2
Close
Sep 27, 2024
Bristol-Myers Squibb
0%
▲ 10.35%
2
Sell
Sep 27, 2024